The upregulated of ATG7 expression was associated with poorer survival in CRC patients diagnosed with MSI-H status, unlike the outcomes observed in those diagnosed with MSS or MSI-L status (Fig. 1L-N). Here, ATG7 is linked to colorectal carcinoma.